ADAM12 and small cell lung carcinoma: The serum ADAM-12 level was significantly higher in SCLC patients than in healthy volunteers (502±234 vs 180±92 pg/ml, P<0.001) and in those with extensive disease compared to those with limited disease (586±205 vs 317±185 pg/ml) (Figure 3D).